Anaphylaxis

>

The HCPLive anaphylaxis page is a comprehensive resource for clinical news and insights on acute allergic reactions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for preventing anaphylaxis, and more.

Latest News

FDA Declines to Approve of Epinephrine Alternative to EpiPen, Requests Further Study
FDA Declines to Approve of Epinephrine Alternative to EpiPen, Requests Further Study

September 20th 2023

The FDA's announcement requesting further study represents a step back in the process of 'neffy' becoming the first needle-free nasal spray epinephrine alternative.

Increasing Age Linked to More Severe Anaphylaxis, Medications Frequent Trigger for Older Adults
Increasing Age Linked to More Severe Anaphylaxis, Medications Frequent Trigger for Older Adults

July 25th 2023

PK Higher, More Sustained for Epinephrine Spray Compared to Current Standard of Care
PK Higher, More Sustained for Epinephrine Spray Compared to Current Standard of Care

February 25th 2023

Study Suggests High Degree Of Sensitization, Severe Reaction To Other Legumes In Children With Peanut Allergies
Study Suggests High Degree Of Sensitization, Severe Reaction To Other Legumes In Children With Peanut Allergies

September 15th 2022

Tolly Epstein, MD, MS: Post-Injection Monitoring and Epinephrine for Patients on Immunotherapy
Tolly Epstein, MD, MS: Post-Injection Monitoring and Epinephrine for Patients on Immunotherapy

February 25th 2022

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.